Treatment Consideration (CDC, 7/24)
Treatment Consideration (CDC, 7/24)
Tecovirimat may be considered for treatment in people infected with Monkeypox virus:
With severe disease
Who are at high risk of severe disease:
With aberrant infections involving accidental implantation in eyes, mouth, or other anatomic areas where Monkeypox virus infection might constitute a special hazard (e.g., the genitals or anus)
TPOXX Access Network (crowdsourced doc managed by different maintainer):
